Caspase signalling in neuropathic and inflammatory pain in the rat
- PMID: 15579143
- DOI: 10.1111/j.1460-9568.2004.03750.x
Caspase signalling in neuropathic and inflammatory pain in the rat
Abstract
Whereas small-fibre sensory neuropathies might ultimately lead to cell death and loss of sensation, they first progress through a phase, which might last for years, characterized by the presence of analgesia-resistant neuropathic dysesthesias and pain. Much previous research has addressed these two phases as separate phenomena mediated by presumably discrete biochemical mechanisms. We hypothesized that activity in signalling pathways that ultimately lead to apoptosis plays a critical role in the generation of neuropathic pain, before death of sensory neurons becomes apparent. We have tested the hypothesis that activator and effector caspases, defining components of programmed cell death (apoptosis) signalling pathways, also contribute to pain-related behaviour in animals with small-fibre peripheral neuropathies and that the death receptor ligand, tumour necrosis factor-alpha, and its downstream second messenger, ceramide, also produce pain-related behaviour via this mechanism. In two models of painful peripheral neuropathy, HIV/AIDS therapy (induced by the nucleoside reverse transcriptase inhibitor, dideoxycytidine), and cancer chemotherapy (induced by vincristine) peripheral neuropathy, and for pain-related behaviour induced by tumour necrosis factor-alpha and its second messenger, ceramide, inhibition of both activator (1, 2, 8 and 9) and effector (3) caspases attenuates neuropathic pain-related behaviour, although has no effect in streptozotocin-diabetic neuropathy and control rats. We conclude that during a latent phase, before apoptotic cell death is manifest, the caspase signalling pathway can contribute to pain in small-fibre peripheral neuropathies, and that inflammatory/immune mediators also activate these pathways. This suggests that these pathways are potential targets for novel pharmacological agents for the treatment of inflammatory as well as neuropathic pain.
Similar articles
-
Mitochondrial electron transport in models of neuropathic and inflammatory pain.Pain. 2006 Mar;121(1-2):105-14. doi: 10.1016/j.pain.2005.12.010. Epub 2006 Feb 10. Pain. 2006. PMID: 16472913
-
Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.J Neurosci. 2011 Aug 3;31(31):11404-10. doi: 10.1523/JNEUROSCI.2223-11.2011. J Neurosci. 2011. PMID: 21813700 Free PMC article.
-
Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat.Pain. 2004 Jan;107(1-2):147-58. doi: 10.1016/j.pain.2003.10.010. Pain. 2004. PMID: 14715401
-
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets.Drug Discov Today. 2006 Jan;11(1-2):8-20. doi: 10.1016/S1359-6446(05)03637-8. Drug Discov Today. 2006. PMID: 16478686 Review.
-
Exploring the molecular pathways and therapeutic implications of angiogenesis in neuropathic pain.Biomed Pharmacother. 2023 Jun;162:114693. doi: 10.1016/j.biopha.2023.114693. Epub 2023 Apr 14. Biomed Pharmacother. 2023. PMID: 37062217 Review.
Cited by
-
Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.Heliyon. 2021 Feb 12;7(2):e06219. doi: 10.1016/j.heliyon.2021.e06219. eCollection 2021 Feb. Heliyon. 2021. Retraction in: Heliyon. 2021 May 17;7(5):e06981. doi: 10.1016/j.heliyon.2021.e06981. PMID: 33644478 Free PMC article. Retracted.
-
Pharmacokinetic and Lipidomic Assessment of the In Vivo Effects of Parishin A-Isorhynchophylline in Rat Migraine Models.J Anal Methods Chem. 2020 Jul 6;2020:9101598. doi: 10.1155/2020/9101598. eCollection 2020. J Anal Methods Chem. 2020. PMID: 32695549 Free PMC article.
-
Animal models of peripheral neuropathies.Neurotherapeutics. 2012 Apr;9(2):262-9. doi: 10.1007/s13311-012-0116-y. Neurotherapeutics. 2012. PMID: 22415319 Free PMC article. Review.
-
Melatonin MT2 receptor agonist IIK-7 produces antinociception by modulation of ROS and suppression of spinal microglial activation in neuropathic pain rats.J Pain Res. 2019 Aug 8;12:2473-2485. doi: 10.2147/JPR.S214671. eCollection 2019. J Pain Res. 2019. PMID: 31496789 Free PMC article.
-
Endoplasmic reticulum stress promoting caspase signaling pathway-dependent apoptosis contributes to bone cancer pain in the spinal dorsal horn.Mol Pain. 2019 Jan-Dec;15:1744806919876150. doi: 10.1177/1744806919876150. Mol Pain. 2019. PMID: 31452457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical